IFNG and neoplasm: Chemotherapy drugs can enhance the recognition and presentation of dendritic cells (DCs), activate cytotoxic T lymphocytes to attack tumors, stimulate the release of interleukin-2 (IL-2), IL-4, and interferon-gamma (IFN-γ), and induce anti-tumor immune responses [22].